Lv1
60 积分 2022-07-15 加入
Management of indolent B-cell Lymphomas: A review of approved and emerging targeted therapies
15小时前
已完结
Characteristics and outcomes in patients with lenalidomide-refractory multiple myeloma treated with 1-3 prior lines of therapy: analysis of individual patient-level data from daratumumab clinical trials
10天前
已完结
Lenalidomide: A Review in Previously Treated Follicular Lymphoma
10天前
已完结
Coadministration with bendamustine restores the antitumor activity of obinutuzumab in obinutuzumab-resistant tumors
2个月前
已完结
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study
2个月前
已关闭
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study
2个月前
已关闭
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
2个月前
已完结
Relationship between response rates and median progression‐free survival in non‐Hodgkin's lymphoma: A meta‐analysis of published clinical trials
2个月前
已完结
Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies
2个月前
已完结
皖公网安备34019202002308
